Abstract
BRCA1 and BRCA2 are highly penetrant breast and ovarian cancer susceptibility genes that are mutated in a significant proportion of familial breast and ovarian cancer syndromes. Both of these genes are tumour suppressors, the products of which play vital roles in the cellular response to DNA damage. These proteins function in a number of cellular pathways in order to maintain genomic stability including DNA damage signaling, DNA repair, cell cycle regulation, protein ubiquitination, chromatin remodeling, transcriptional regulation and apoptosis. This chapter will discuss the functions of these proteins and how they relate to tumour development, and therapy.
| Original language | English |
|---|---|
| Title of host publication | The DNA Damage Response: Implications on Cancer Formation and Treatment |
| Publisher | Springer |
| Pages | 415-443 |
| Number of pages | 29 |
| ISBN (Print) | 9789048125609 |
| DOIs | |
| Publication status | Published - 2009 |
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
Fingerprint Dive into the research topics of 'Brca1 and brca2: Role in the DNA damage response, cancer formation and treatment'. Together they form a unique fingerprint.
Cite this
Savage, K., & Harkin, D. P. (2009). Brca1 and brca2: Role in the DNA damage response, cancer formation and treatment. In The DNA Damage Response: Implications on Cancer Formation and Treatment (pp. 415-443). Springer. https://doi.org/10.1007/978-90-481-2561-6_18